(Q64130811)

2

0 references

L Gustafsson

3

0 references

J Storsaeter

4

0 references

P Olin

Vaccine immunity to diphtheria: a 20-year follow-up study.

5

0 references

language of work or name

English

0 references

publication date

28 April 2000

0 references

published in

Vaccine

0 references

volume

18

0 references

issue

21

0 references

page(s)

2295-306

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900539-3

7 January 2021

Serological immunity to diphtheria in Sweden in 1978 and 1984

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900539-3

7 January 2021

Immunity and immunization of children against diphtheria in Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900539-3

7 January 2021

Immunity against diphtheria and tetanus in the age group 30-70 years

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900539-3

7 January 2021

Factors influencing immunity against diphtheria in adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900539-3

7 January 2021

Diphtheria immunity in UK blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900539-3

7 January 2021

Diphtheria immunity in Flanders

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900539-3

7 January 2021

Absence of protective immunity against diphtheria in a large proportion of young adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900539-3

7 January 2021

Antitoxin antibody levels and the outcome of illness during an outbreak of diphtheria among alcoholics

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900539-3

7 January 2021

Diphtheria outbreaks in immunized populations

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900539-3

7 January 2021

Epidemiological typing of Corynebacterium diphtheriae isolated in Sweden 1984-1986.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900539-3

7 January 2021

Risk of diphtheria among schoolchildren in the Russian Federation in relation to time since last vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900539-3

7 January 2021

A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900539-3

7 January 2021

Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900539-3

7 January 2021

Immunoenzymatic assay of anti-diphtheric toxin antibodies in human serum

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900539-3

7 January 2021

Evaluation of single- and dual antigen delayed fluorescence immunoassay in comparison to an ELISA and the in vivo toxin neutralisation test for detection of diphtheria toxin antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900539-3

7 January 2021

Duration of immunity to diphtheria and tetanus after active immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900539-3

7 January 2021

Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3, and 4 months versus 3, 5, and 9 months of age

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900539-3

7 January 2021

Fall-off in immunity following diphtheria revaccination--an 8 year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900539-3

7 January 2021

Evaluation of a new highly purified pertussis vaccine in infants and children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900539-3

7 January 2021

Acellular pertussis vaccine: immunogenicity and safety of an acellular pertussis vs. a whole cell pertussis vaccine combined with diphtheria and tetanus toxoids as a booster in 18- to 24-month old children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900539-3

7 January 2021

Determination of diphtheria toxin neutralizing antibody titers with a cell protein synthesis inhibition assay

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900539-3

7 January 2021

Testing for neutralising potential of serum antibodies to tetanus and diphtheria toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900539-3

7 January 2021

Diphtheria, pertussis, and tetanus vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900539-3

7 January 2021

Estimation of Corynebacterium diphtheriae antitoxin in human sera: A comparison of an enzyme-linked immunosorbent assay with the toxin neutralisation test

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900539-3

7 January 2021

Diphtheria antitoxin levels in US blood and plasma donors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900539-3

7 January 2021

Improvement of a Vero cell assay to determine diphtheria antitoxin content in sera

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900539-3

7 January 2021